Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131207 · ClinicalTrials.gov registry record
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 139
- Enrollment target
NCT02131207: Clinical Trial study, sponsored by Case Comprehensive Cancer Center.
NCT02131207 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02131207 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 139 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. This diagnostic procedure may aid in identifying lesions in the prostate which may have cancer. The lesions can then be targeted during the prostate biopsy to improve the accuracy of identifying prostate cancer.
Primary Outcome
Percent increase of patients with positive prostate cancer biopsies detected with pelvic MRI quick scan from the anticipated detection rate of 40%
Interventions
- DEVICE magnetic resonance imaging
- PROCEDURE prostate biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2014-09-10 |
| Est. Completion | 2017-12-08 |
Why NCT02131207 stopped before completion
NCT02131207 is an observational study that tracks outcomes without assigning an intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which magnetic resonance imaging is the first listed.
NCT02131207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02131207 about?
NCT02131207 is a clinical study titled "MRI Before Biopsy in Diagnosing Patients With Prostate Cancer". This pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. This diagnost...
What is the current status of trial NCT02131207?
This trial is currently terminated. The enrollment target is 139 participants. The study started on 2014-09-10. Estimated completion is 2017-12-08.
What interventions are being tested in trial NCT02131207?
The interventions under investigation include: magnetic resonance imaging (DEVICE), prostate biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02131207?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI